✦ LIBER ✦

The higher barrier of darunavir and tipranavir resistance for HIV-1 protease

✍ Scribed by Yong Wang; Zhigang Liu; Joseph S. Brunzelle; Iulia A. Kovari; Tamaria G. Dewdney; Samuel J. Reiter; Ladislau C. Kovari

Book ID: 116302241
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 801 KB
Volume: 412
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2011.08.045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thermodynamic and structural analysis of

Thermodynamic and structural analysis of HIV protease resistance to darunavir - analysis of heavily mutated patient-derived HIV-1 proteases

✍ Kožíšek, Milan; Lepšík, Martin; Grantz Šašková, Klára; Brynda, Jiří; Konvalinka, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

ChemInform Abstract: Darunavir (I), a Co

ChemInform Abstract: Darunavir (I), a Conceptually New HIV-1 Protease Inhibitor for the Treatment of Drug-Resistant HIV.

✍ Arun K. Ghosh; Zachary L. Dawson; Hiroaki Mitsuya 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 18 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Structural basis for the resilience of D

Structural basis for the resilience of Darunavir (TMC114) resistance major flap mutations of HIV-1 protease

✍ Rituraj Purohit; Rao Sethumadhavan 📂 Article 📅 2009 🏛 International Association of Scientists in the Int 🌐 English ⚖ 221 KB

Relative antiviral efficacy of ritonavir

Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials

✍ A Hill; G Moyle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Selection and characterization of HIV-1

Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir

✍ Louise Doyon; Sonia Tremblay; Lise Bourgon; Elizabeth Wardrop; Michael G. Cordin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Bis-Tetrahydrofuran: a Privileged Ligand

Bis-Tetrahydrofuran: a Privileged Ligand for Darunavir and a New Generation of HIV Protease Inhibitors That Combat Drug Resistance

✍ Arun K. Ghosh; Perali Ramu Sridhar; Nagaswamy Kumaragurubaran; Yasuhiro Koh; Ire 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 2 views